Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.19754673560745.5730
Domestic EquitiesCipla Ltd.9.43134742991627.9720
Domestic EquitiesDr. Reddy's Laboratories Ltd.7.26843973068483.9594
Domestic EquitiesMankind Pharma Ltd.6.33751986722421.9798
Domestic EquitiesDivi's Laboratories Ltd.6.2221684674414.2962
Domestic EquitiesBiocon Ltd.5.852910624677389.7132
Domestic EquitiesLupin Ltd.4.79951484426319.5672
Domestic EquitiesAurobindo Pharma Ltd.3.91002155679260.3414
Domestic EquitiesSyngene International Ltd.2.99044205528199.1107
Domestic EquitiesAlkem Laboratories Ltd.2.8988339961193.0129
Domestic EquitiesCohance Lifesciences Ltd.2.79994889358186.4312
Domestic EquitiesZydus Lifesciences Ltd.2.34171761233155.9220
Domestic EquitiesAlivus Life Sciences Ltd.2.27581576714151.5301
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.79161523120119.2908
Domestic EquitiesThyrocare Technologies Ltd.1.76902804472117.7878
Domestic EquitiesAkums Drugs and Pharmaceuticals Ltd.1.62862467084108.4407
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.6249578725108.1926
Domestic EquitiesEntero Healthcare Solutions1.5954961455106.2312
Domestic EquitiesGland Pharma Ltd.1.5944574908106.1625
Domestic EquitiesMedplus Health Services Ltd1.4474120621796.3707
Domestic EquitiesMedi Assist Healthcare Services Ltd1.4421240773996.0206
Domestic EquitiesPfizer Ltd.1.240318097082.5875
Domestic EquitiesMetropolis Healthcare Ltd.1.232543815582.0664
Domestic EquitiesBlue Jet Healthcare Ltd.1.1601184905777.2444
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.146937882276.3667
Domestic EquitiesHikal Ltd.1.1456396103176.2815
Domestic EquitiesWindlas Biotech Ltd.1.093485765172.8060
Domestic EquitiesFine Organic Industries Ltd.1.085917039972.3054
Domestic EquitiesAarti Drugs Ltd.1.0439182416769.5099
Domestic EquitiesAnthem Biosciences Ltd0.9474105263663.0845
Domestic EquitiesSanofi Consumer Healthcare India Ltd0.851613352556.7054
Domestic EquitiesShilpa Medicare Ltd.0.8504195953156.6206
Domestic EquitiesSenores Pharmaceuticals Ltd0.758464088350.4984
Domestic EquitiesAstrazeneca Pharma India Ltd.0.74845828249.8311
Domestic EquitiesRubicon Research Ltd0.741672168049.3810
Domestic EquitiesFDC Ltd.0.6795119768945.2427
Domestic EquitiesLaxmi Dental Ltd.0.6267220785941.7285
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.4570241330830.4270
Domestic EquitiesNephrocare Health Services Ltd0.435854991729.0191
Domestic EquitiesProcter & Gamble Health Ltd.0.1336167788.8974
Total 97.5985 6498.5095
Cash & Cash Equivalents and Net AssetsTREPS2.4756 164.8367
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.0061 0.4052
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.1099 -7.3192
Total 2.3718 157.9227
Treasury Bills91 Days Treasury Bills0.02972000001.9803
Total 0.0297 1.9803
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.